Israel kills more than 80 people in Gaza, including dozens of aid seekers
In Rafah alone, in the south of the enclave, 27 aid seekers were gunned down by the Israeli military on Tuesday.
The overall death toll from Israel's war has risen to 56,077 killed and 131,848 injuries since October 7, 2023.
The killings are the latest in a wave of daily carnage near aid distribution points established late last month by the controversial Israeli and United States-backed Gaza Humanitarian Foundation (GHF), which the head of the United Nations agency for Palestinian refugees (UNWRA) has labelled a 'death trap'.
Medical sources reported that at least 25 people were killed in an incident on Salah al-Din Street south of Wadi Gaza in central Gaza, according to The Associated Press news agency. More than 140 other people were injured, 62 of them critically.
Footage posted on social media site Instagram, and verified by Al Jazeera's Sanad agency, showed bodies being brought to al-Awda Hospital in the nearby Nuseirat refugee camp.
Similar scenes were reported from the Nasser Medical Complex to the south in Khan Younis, following unverified reports that the Israeli army had targeted people waiting for aid on al-Tina Street.
People approaching an aid point in Gaza City were also killed, Al Jazeera's Hani Mahmoud reported from the city in the north of the territory, as well as Rafah in the south.
'Casualties were brought to various health facilities, including al-Shifa Hospital [in Gaza City],' he said. 'The emergency ward there turned into a bloodbath, and many died waiting for medical care.'
Witnesses told the AP that Israeli forces had opened fire as people were approaching the aid trucks.
'It was a massacre,' said Ahmed Halawa, reporting that tanks and drones had fired 'even as we were fleeing'.
The Israeli military said it was reviewing reports of casualties from fire by its troops after a group of people approached soldiers in an area near the militarised Netzarim Corridor.
Israel has said that previous shootings near GHF aid sites have been provoked by the approach of 'suspects' towards soldiers.
Witnesses and humanitarian groups have said that many of the shootings took place without warning.The killing of aid seekers has become an almost daily occurrence since the Gaza Humanitarian Foundation (GHF) took over the distribution of food and other vital supplies.
The foundation launched its aid distribution programme in late May after Israel had completely cut off supplies into Gaza for more than two months, prompting warnings of mass famine.
The United Nations has refused to work with the GHF, citing concerns that it prioritises Israeli military objectives over humanitarian needs, and condemned it for its 'weaponisation' of aid.
The GHF distribution sites have been plagued by scenes of chaos and carnage. More than 400 people have been killed and 1,000 wounded by Israeli soldiers since the GHF aid rollout began.
The head of the UN agency for Palestinian refugees, Philippe Lazzarini, said on Tuesday that the system for aid distribution in Gaza was 'an abomination'.
'The newly created so-called aid mechanism is an abomination that humiliates and degrades desperate people,' said at a news conference in Berlin. 'It is a death trap costing more lives than it saves.'
In a letter published on Monday, the International Commission of Jurists — a human rights NGO of prominent lawyers and judges — joined 14 other groups in condemning the GHF and calling for 'an end to private militarized humanitarian aid operations in Gaza'.
Philip Grant, executive director of Geneva-based NGO TRIAL International, said GHF's model of militarised and privatised aid delivery 'violates core humanitarian principles'.
He added that those who enabled or profited from the GHF's work faced a 'real risk of prosecution for complicity in war crimes, including the forcible transfer of civilians and the starvation of civilians as a method of warfare'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
9 hours ago
- CNN
Over-the-counter birth control pills have been available in the US for over a year. Here's who's using them
About two years after the US Food and Drug Administration approved the first over-the-counter birth control pill in the United States, a new study suggests that many people who may not have had access to contraception before are now using the over-the-counter option. More than a quarter – 26.2% – of people now using over-the-counter oral contraceptives were using no modern method of birth control before, according to the study published Monday in the medical journal JAMA Network Open. People relying on the over-the-counter birth control pill, which requires no prescription, are more likely to be uninsured, adolescents and living in rural areas, the study found. Not having health insurance and residing in rural areas are two of the main barriers for people trying to access any health care, said the study's lead author, Dr. Maria Rodriguez, professor of obstetrics and gynecology at Oregon Health & Science University in Portland and director of the OHSU Center for Women's Health. In July 2023, the FDA approved the birth control pill Opill to be available over-the-counter, making it the first nonprescription birth control pill available in the United States. In March 2024, the first shipments of Opill were sent to distributors, major drug stores and pharmacies. The pills became available in many retail pharmacy chains such as CVS, Walgreens and Walmart, costing $19.99 for a one-month supply, $49.99 for a three-month supply and $89.99 for a six-month pack. 'This pill is basically reaching the exact populations that need it the most, people with structural barriers to health care, and people that are at the greatest risk for the harms that come along with unintended pregnancy, in a country where we have a maternal health crisis and access to safe abortion is limited,' Rodriguez said. Rodriguez and her OHSU colleagues surveyed 986 people, ages 15 to 45, using an online questionnaire, asking specifically about their contraceptive use. The study participants were from 49 states, Rodriguez said, and they had obtained some form of oral contraceptive pills at pharmacy stores or online between April 2024 and February 2025. The researchers found that 32.5% of the study participants had used over-the-counter birth control pills. The survey data showed that having access to over-the-counter birth control pills was associated with an increase of 31.8 percentage points in switching to using the over-the-counter pill after using no contraception. 'Giving that choice to people who can become pregnant, to control their own access to contraception, I think is really powerful,' Rodriguez said. 'It's also something that is done around the globe. The US is really delayed in making a form of oral contraception available over the counter. Over 30 countries around the world have had this available for use for many years, and we know that it's safe and effective.' The survey data also revealed that one of the most common reasons why the study participants said they were using the over-the-counter birth control pill was because it did not require a doctor's appointment to get a prescription. 'Not having insurance makes it a lot harder to be able to afford to get into a clinic to get any kind of care that's preventative,' Rodriguez said, adding that people living in rural areas often have limited options for reproductive health care. 'We're seeing that with labor and delivery units closing due to costs, a shrinking of the contraceptive workforce, and then there's the suggestion that we also are seeing some providers leaving states post-Dobbs too, all of which is impacting contraceptive access for people.' The researchers wrote that their study provides a 'first look' at who is using over-the-counter oral contraceptive pills, 'as the method has been available in the US for only approximately a year.' And while the study estimates what the early uptake of over-the-counter birth control pills has been in the past year, more research is needed to assess how that uptake may change over time and what impact it may have on unintended pregnancy rates. Opill was approved by the FDA without age restrictions and is 'suitable for most people of reproductive age to use to prevent pregnancy,' according to its website. Opill works as a 'mini-pill,' using only the hormone progestin to prevent pregnancy. It's a different formulation than what is in combination hormonal birth control pills, which contain both progestin and estrogen. Combined birth control pills may carry risks for people with uncontrolled hypertension or blood clot risks for smokers older than 35. Contraindications for progestin-only pills include conditions such as breast cancer or liver disease, or the use of certain medications. When taken as directed at the same time every day, Opill has been found to be 98% effective at preventing pregnancy, according to Perrigo, the company behind the product. Most birth control pills are up to 99% effective at preventing pregnancy if taken as instructed every day. Last year, when Opill first became available, public health experts anticipated that it would benefit women living in remote rural areas, Dr. Anne-Marie Amies Oelschlager, professor of obstetrics and gynecology at the University of Washington School of Medicine, who specializes in adolescent care, said at the time. 'The biggest population that will benefit from this are those who have limited access to contraception in the first place,' Oelschlager said last year. 'There are a lot of people in our country that live in what we would call contraceptive deserts, and these are areas where they have limited to no access to a reproductive health care provider, meaning they'd have to drive really far away to be able to access a provider.' The more avenues through which people can access contraception – whether it's over the counter in a store or online – the more control they can have over their reproductive health and choices, Megan Kavanaugh, a principal research scientist at the Guttmacher Institute, a nonprofit that has been tracking the rollout of Opill, said last year. 'It's a huge milestone that Opill is available over the counter,' she said last year. 'And I think we should really celebrate the milestone, and we should situate this milestone on this trajectory of always wanting to move towards increased access for all people.'
CNN
9 hours ago
- CNN
Over-the-counter birth control pills have been available in the US for over a year. Here's who's using them
About two years after the US Food and Drug Administration approved the first over-the-counter birth control pill in the United States, a new study suggests that many people who may not have had access to contraception before are now using the over-the-counter option. More than a quarter – 26.2% – of people now using over-the-counter oral contraceptives were using no modern method of birth control before, according to the study published Monday in the medical journal JAMA Network Open. People relying on the over-the-counter birth control pill, which requires no prescription, are more likely to be uninsured, adolescents and living in rural areas, the study found. Not having health insurance and residing in rural areas are two of the main barriers for people trying to access any health care, said the study's lead author, Dr. Maria Rodriguez, professor of obstetrics and gynecology at Oregon Health & Science University in Portland and director of the OHSU Center for Women's Health. In July 2023, the FDA approved the birth control pill Opill to be available over-the-counter, making it the first nonprescription birth control pill available in the United States. In March 2024, the first shipments of Opill were sent to distributors, major drug stores and pharmacies. The pills became available in many retail pharmacy chains such as CVS, Walgreens and Walmart, costing $19.99 for a one-month supply, $49.99 for a three-month supply and $89.99 for a six-month pack. 'This pill is basically reaching the exact populations that need it the most, people with structural barriers to health care, and people that are at the greatest risk for the harms that come along with unintended pregnancy, in a country where we have a maternal health crisis and access to safe abortion is limited,' Rodriguez said. Rodriguez and her OHSU colleagues surveyed 986 people, ages 15 to 45, using an online questionnaire, asking specifically about their contraceptive use. The study participants were from 49 states, Rodriguez said, and they had obtained some form of oral contraceptive pills at pharmacy stores or online between April 2024 and February 2025. The researchers found that 32.5% of the study participants had used over-the-counter birth control pills. The survey data showed that having access to over-the-counter birth control pills was associated with an increase of 31.8 percentage points in switching to using the over-the-counter pill after using no contraception. 'Giving that choice to people who can become pregnant, to control their own access to contraception, I think is really powerful,' Rodriguez said. 'It's also something that is done around the globe. The US is really delayed in making a form of oral contraception available over the counter. Over 30 countries around the world have had this available for use for many years, and we know that it's safe and effective.' The survey data also revealed that one of the most common reasons why the study participants said they were using the over-the-counter birth control pill was because it did not require a doctor's appointment to get a prescription. 'Not having insurance makes it a lot harder to be able to afford to get into a clinic to get any kind of care that's preventative,' Rodriguez said, adding that people living in rural areas often have limited options for reproductive health care. 'We're seeing that with labor and delivery units closing due to costs, a shrinking of the contraceptive workforce, and then there's the suggestion that we also are seeing some providers leaving states post-Dobbs too, all of which is impacting contraceptive access for people.' The researchers wrote that their study provides a 'first look' at who is using over-the-counter oral contraceptive pills, 'as the method has been available in the US for only approximately a year.' And while the study estimates what the early uptake of over-the-counter birth control pills has been in the past year, more research is needed to assess how that uptake may change over time and what impact it may have on unintended pregnancy rates. Opill was approved by the FDA without age restrictions and is 'suitable for most people of reproductive age to use to prevent pregnancy,' according to its website. Opill works as a 'mini-pill,' using only the hormone progestin to prevent pregnancy. It's a different formulation than what is in combination hormonal birth control pills, which contain both progestin and estrogen. Combined birth control pills may carry risks for people with uncontrolled hypertension or blood clot risks for smokers older than 35. Contraindications for progestin-only pills include conditions such as breast cancer or liver disease, or the use of certain medications. When taken as directed at the same time every day, Opill has been found to be 98% effective at preventing pregnancy, according to Perrigo, the company behind the product. Most birth control pills are up to 99% effective at preventing pregnancy if taken as instructed every day. Last year, when Opill first became available, public health experts anticipated that it would benefit women living in remote rural areas, Dr. Anne-Marie Amies Oelschlager, professor of obstetrics and gynecology at the University of Washington School of Medicine, who specializes in adolescent care, said at the time. 'The biggest population that will benefit from this are those who have limited access to contraception in the first place,' Oelschlager said last year. 'There are a lot of people in our country that live in what we would call contraceptive deserts, and these are areas where they have limited to no access to a reproductive health care provider, meaning they'd have to drive really far away to be able to access a provider.' The more avenues through which people can access contraception – whether it's over the counter in a store or online – the more control they can have over their reproductive health and choices, Megan Kavanaugh, a principal research scientist at the Guttmacher Institute, a nonprofit that has been tracking the rollout of Opill, said last year. 'It's a huge milestone that Opill is available over the counter,' she said last year. 'And I think we should really celebrate the milestone, and we should situate this milestone on this trajectory of always wanting to move towards increased access for all people.'
CNN
9 hours ago
- CNN
Over-the-counter birth control pills have been available in the US for over a year. Here's who's using them
About two years after the US Food and Drug Administration approved the first over-the-counter birth control pill in the United States, a new study suggests that many people who may not have had access to contraception before are now using the over-the-counter option. More than a quarter – 26.2% – of people now using over-the-counter oral contraceptives were using no modern method of birth control before, according to the study published Monday in the medical journal JAMA Network Open. People relying on the over-the-counter birth control pill, which requires no prescription, are more likely to be uninsured, adolescents and living in rural areas, the study found. Not having health insurance and residing in rural areas are two of the main barriers for people trying to access any health care, said the study's lead author, Dr. Maria Rodriguez, professor of obstetrics and gynecology at Oregon Health & Science University in Portland and director of the OHSU Center for Women's Health. In July 2023, the FDA approved the birth control pill Opill to be available over-the-counter, making it the first nonprescription birth control pill available in the United States. In March 2024, the first shipments of Opill were sent to distributors, major drug stores and pharmacies. The pills became available in many retail pharmacy chains such as CVS, Walgreens and Walmart, costing $19.99 for a one-month supply, $49.99 for a three-month supply and $89.99 for a six-month pack. 'This pill is basically reaching the exact populations that need it the most, people with structural barriers to health care, and people that are at the greatest risk for the harms that come along with unintended pregnancy, in a country where we have a maternal health crisis and access to safe abortion is limited,' Rodriguez said. Rodriguez and her OHSU colleagues surveyed 986 people, ages 15 to 45, using an online questionnaire, asking specifically about their contraceptive use. The study participants were from 49 states, Rodriguez said, and they had obtained some form of oral contraceptive pills at pharmacy stores or online between April 2024 and February 2025. The researchers found that 32.5% of the study participants had used over-the-counter birth control pills. The survey data showed that having access to over-the-counter birth control pills was associated with an increase of 31.8 percentage points in switching to using the over-the-counter pill after using no contraception. 'Giving that choice to people who can become pregnant, to control their own access to contraception, I think is really powerful,' Rodriguez said. 'It's also something that is done around the globe. The US is really delayed in making a form of oral contraception available over the counter. Over 30 countries around the world have had this available for use for many years, and we know that it's safe and effective.' The survey data also revealed that one of the most common reasons why the study participants said they were using the over-the-counter birth control pill was because it did not require a doctor's appointment to get a prescription. 'Not having insurance makes it a lot harder to be able to afford to get into a clinic to get any kind of care that's preventative,' Rodriguez said, adding that people living in rural areas often have limited options for reproductive health care. 'We're seeing that with labor and delivery units closing due to costs, a shrinking of the contraceptive workforce, and then there's the suggestion that we also are seeing some providers leaving states post-Dobbs too, all of which is impacting contraceptive access for people.' The researchers wrote that their study provides a 'first look' at who is using over-the-counter oral contraceptive pills, 'as the method has been available in the US for only approximately a year.' And while the study estimates what the early uptake of over-the-counter birth control pills has been in the past year, more research is needed to assess how that uptake may change over time and what impact it may have on unintended pregnancy rates. Opill was approved by the FDA without age restrictions and is 'suitable for most people of reproductive age to use to prevent pregnancy,' according to its website. Opill works as a 'mini-pill,' using only the hormone progestin to prevent pregnancy. It's a different formulation than what is in combination hormonal birth control pills, which contain both progestin and estrogen. Combined birth control pills may carry risks for people with uncontrolled hypertension or blood clot risks for smokers older than 35. Contraindications for progestin-only pills include conditions such as breast cancer or liver disease, or the use of certain medications. When taken as directed at the same time every day, Opill has been found to be 98% effective at preventing pregnancy, according to Perrigo, the company behind the product. Most birth control pills are up to 99% effective at preventing pregnancy if taken as instructed every day. Last year, when Opill first became available, public health experts anticipated that it would benefit women living in remote rural areas, Dr. Anne-Marie Amies Oelschlager, professor of obstetrics and gynecology at the University of Washington School of Medicine, who specializes in adolescent care, said at the time. 'The biggest population that will benefit from this are those who have limited access to contraception in the first place,' Oelschlager said last year. 'There are a lot of people in our country that live in what we would call contraceptive deserts, and these are areas where they have limited to no access to a reproductive health care provider, meaning they'd have to drive really far away to be able to access a provider.' The more avenues through which people can access contraception – whether it's over the counter in a store or online – the more control they can have over their reproductive health and choices, Megan Kavanaugh, a principal research scientist at the Guttmacher Institute, a nonprofit that has been tracking the rollout of Opill, said last year. 'It's a huge milestone that Opill is available over the counter,' she said last year. 'And I think we should really celebrate the milestone, and we should situate this milestone on this trajectory of always wanting to move towards increased access for all people.'
